Data_Sheet_1_Reversible Bronchiectasis in COVID-19 Survivors With Acute Respiratory Distress Syndrome: Pseudobronchiectasis.docx
To retrospectively analyze whether traction bronchiectasis was reversible in coronavirus disease 2019 (COVID-19) survivors with acute respiratory distress syndrome (ARDS), and whether computed tomography (CT) findings were associated with the reversibility, 41 COVID-19 survivors with ARDS were followed-up for more than 4 months. Demographics, clinical data, and all chest CT images were collected. The follow-up CT images were compared with the previous CT scans. There were 28 (68%) patients with traction bronchiectasis (Group I) and 13 (32%) patients without traction bronchiectasis (Group II) on CT images. Traction bronchiectasis disappeared completely in 21 of the 28 (75%) patients (Group IA), but did not completely disappear in seven of the 28 (25%) patients (Group IB). In the second week after onset, the evaluation score on CT images in Group I was significantly higher than that in Group II (p = 0.001). The proportion of reticulation on the last CT images in Group IB was found higher than that in Group IA (p < 0.05). COVID-19 survivors with ARDS might develop traction bronchiectasis, which can be absorbed completely in most patients. Traction bronchiectasis in a few patients did not disappear completely, but bronchiectasis was significantly relieved. The long-term follow-up is necessary to further assess whether traction bronchiectasis represents irreversible fibrosis.
History
References
- https://doi.org//10.1038/s41564-020-0695-z
- https://doi.org//10.1016/S0140-6736%2820%2930633-4
- https://doi.org//10.1001/jama.2020.2648
- https://doi.org//10.1016/S2213-2600%2820%2930056-4
- https://doi.org//10.4187/respcare.01731
- https://doi.org//10.1148/radiology.210.1.r99ja2629
- https://doi.org//10.1148/radiol.2303030894
- https://doi.org//10.1007/s00330-020-06801-0
- https://doi.org//10.1148/radiol.2020209021
- https://doi.org//10.1053/crad.2001.0889
- https://doi.org//10.1016/S0009-9260%2898%2980055-X
- https://doi.org//10.1136/jclinpath-2020-206522
- https://doi.org//10.1148/radiol.2020200280
- https://doi.org//10.1016/j.radcr.2020.08.008
- https://doi.org//10.1177/2040622320982171
- https://doi.org//10.1007/s00330-010-1979-0
- https://doi.org//10.1148/radiol.2462070712
- https://doi.org//10.1056/NEJM196806202782501
- https://doi.org//10.1136/thx.39.5.390
- https://doi.org//10.1016/j.rmcr.2019.03.002
- https://doi.org//10.1136/thx.2010.140574
- https://doi.org//10.1164/ajrccm.186.3.292
- https://doi.org//10.1097/MD.0000000000015048
- https://doi.org//10.1148/68.2.204
- https://doi.org//10.1148/71.3.375
- https://doi.org//10.1097/LBR.0b013e31826ca79d
- https://doi.org//10.1016/j.rmcr.2021.101342
- https://doi.org//10.1001/jama.2012.5669
- https://doi.org//10.2214/ajr.165.2.7618537
- https://doi.org//10.1259/0007-1285-62-733-1
- https://doi.org//10.1148/radiol.2020200463
- https://doi.org//10.1148/radiol.2020200843
- https://doi.org//10.1148/radiol.2373041515
- https://doi.org//10.1016/j.ejrad.2020.109073
- https://doi.org//10.1097/CCM.0b013e31826a5062
- https://doi.org//10.1001/archinte.1953.00240130086009
- https://doi.org//10.1016/S0140-6736%2820%2930566-3
- https://doi.org//10.1056/NEJMoa2004500
- https://doi.org//10.1016/S2213-2600%2820%2930076-X
- https://doi.org//10.1148/radiol.2020200370
Usage metrics
Read the peer-reviewed publication
Categories
- Radiology and Organ Imaging
- Foetal Development and Medicine
- Obstetrics and Gynaecology
- Primary Health Care
- Medical and Health Sciences not elsewhere classified
- Dermatology
- Emergency Medicine
- Gastroenterology and Hepatology
- Geriatrics and Gerontology
- Intensive Care
- Medical Genetics (excl. Cancer Genetics)
- Nephrology and Urology
- Nuclear Medicine
- Orthopaedics
- Otorhinolaryngology
- Pathology (excl. Oral Pathology)
- Family Care